Jeff Jonas

Jeffrey Jonas serves as Chairman at Kenai Therapeutics and Noema Pharma, and holds the position of Partner at Cure Ventures. Additionally, Jeffrey is a Director at Generation Bio and Sage Therapeutics, with previous directorship at Karuna Therapeutics. Jeffrey held the role of Chief Executive Officer at ABio-X and has extensive experience at Shire Pharmaceuticals, where responsibilities included President of Shire Regenerative Medicine and Senior Vice President roles. Prior to Shire, Jeffrey served as EVP at both Isis Pharmaceuticals and Forest Laboratories. Educational credentials include an MD from Harvard Medical School and a BA in Biology/English from Amherst College.